Metallogels constitute a rapidly expanding class of hybrid soft materials in which metal ions, metal complexes, or metal-containing nanoparticles play a decisive structural and functional role within a three-dimensional gel network. Their unique combination of supramolecular assembly, metal-ligand coordination, and dynamic network behaviour provides tunable mechanical, optical, electrical, redox, and catalytic properties that are not accessible in conventional hydrogels or organogels. This review systematically summarises current knowledge on metallogels, beginning with a classification based on matrix type, dominant metal interaction and functional output, spanning metallohydrogels, metal-organic gels, metal-phenolic gels, nanoparticle-based gels, polymer-based metallogels and low-molecular-weight metallogels. Key synthesis pathways are discussed, including coordination-chemistry-driven formation, metal-ligand self-assembly, in situ reduction, diffusion-mediated strategies, sol-gel-like polymerisation, enzyme-assisted routes, and bio-derived fabrication. Particular emphasis is placed on structure-function relationships that enable the development of catalytic, conductive, luminescent, antimicrobial, and biomedical metallogels. The examples compiled here highlight the versatility and transformative potential of metallogels in next-generation soft technologies, including sensing, energy conversion, wound healing, drug delivery, and emerging applications such as soft electronics and on-skin catalytic or bioactive patches. By mapping current progress and emerging design principles, this review aims to support the rational engineering of metallogels for advanced technological and biomedical applications

Beer is a drink that has been a staple in human history, evolving from its beginning in antiquity to the present day. Nowadays, large breweries and other companies have set up laboratories focused on finding and developing new yeast strains for the brewing sector to meet consumers’ demand for new beer styles. Monascus spp. are ascomycota that have been known for hundreds of years. They are widely popular in Asian cuisine, especially in fermented foods. Studies show that Monascus spp. produce numerous food dyes and substances that positively influence human health. In the presented work, Monascus ruber was tested as a potential microorganism for the beer industry. Experiments included fermentation trials with Monascus ruber in four regimes: in aerobic condition, anaerobic condition, anaerobic condition with pH kept above 4.5, and in anaerobic condition with pH set to 4.5. As a reference, commercial Saccharomyces cerevisiae and Saccharomyces pastorianus were used. Fermentation parameters were evaluated by measurements of ethanol and extract level. The final product was tested for its colour in order to evaluate if monascus-derived pigments were present in the beverage. Moreover, a qualitative analysis of lovastatin and citrinin was performed in order to check if those monascus metabolites were present. Finally, small-scale consumer tests were performed in order to check the organoleptic properties of the obtained beverage. Results show that Monascus ruber is able to ferment beer wort in a similar manner as Saccharomyces strains, reaching a slightly lower degree of attenuation. Nevertheless, a longer lag phase was observed in monascus trials, except for the trial with preset pH at 4.5. The most visible change in the product was a reddish colour that appeared in the sample in aerobic conditions. The qualitative analysis showed that lovastatin and citrinin were present in the tested samples. Consumer tests show that experimental beer has a different taste than Saccharomyces-fermented products. Although the presented results are preliminary, they could be a good starting point for further research on monascus-based beverages.

The paper presents a model of drug penetration into infected gingival mucosa via hydrogel overlays, which can be fully or partially covered with a polymer with limited permeability. The general geometry of the single drug carrier (single hydrogel overlay) was proposed as a flat cuboid with a triangular base. The number of overlays depends on the size of the infected area. The model assumptions were formulated to account for the unsteady diffusion of the component within the carrier, the tissue, and the biofilm formed by pathogens, as well as for diffusion and convective transport in the liquid phase. The system of corresponding differential equations was solved using CFD methods. Based on the modelling, the influence of key parameters such as polymer coverage of the carrier and hydrogel layer thickness was determined. It was demonstrated that external carrier coverage is crucial for effective, long-term therapy. Simulations showed that impermeable surfaces facing saliva slowed release by over 9-fold. Rendering those surfaces impermeable is especially desirable as the flow velocity increases. The distribution of the ingredient mass between system domains depends substantially on geometry, with hydrogel thickness influencing release dynamics.